Detection of SARS-CoV-2 in peritoneal fluid from patients with kidney disease and COVID-19: report of two cases
Margarita Ibarra-Hernández(Universidad de Guadalajara), Jaime Andrade‐Villanueva(Hospital Civil de Guadalajara), María de la Luz Alcantar-Vallín(Hospital Civil de Guadalajara), Rodolfo Ismael Cabrera-Silva(Universidad de Guadalajara), Sara A. Aguirre-Díaz(Universidad de Guadalajara), Roxana García-Salcido(Hospital Civil de Guadalajara), Karina Sánchez-Reyes(Universidad de Guadalajara), Monserrat Álvarez-Zavala(Universidad de Guadalajara), Guillermo García-García, Luz Alicia González-Hernández(Universidad de Guadalajara), Vida Verónica Ruíz-Herrera(Hospital Civil de Guadalajara), Judith C. De Arcos-Jiménez(Universidad de Guadalajara)
Cited by 1
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
|The Lancet Respiratory Medicine|2021|225
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
|The Lancet Infectious Diseases|2011|172
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169